The first Avenue Therapeutics trade was made in Q1 2019.
Since then Jim Simons bought shares eight more times and sold shares on six occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Avenue Therapeutics anymore.
Avg closing price
Price range
Sold -16 Thousand shares
Q2 2023
Avg closing price
$82.35
Price range
$68.17
-
$96.74
New holding (+16 Thousand shares)
Q1 2023
Avg closing price
$92.39
Price range
$78.00
-
$149.25
Sold -8.29 Thousand shares
Q3 2022
Avg closing price
$306.60
Price range
$4.50
-
$756.00
New holding (+8.29 Thousand shares)
Q2 2022
Avg closing price
$385.18
Price range
$247.50
-
$628.99
Sold -7.87 Thousand shares
Q4 2021
Avg closing price
$1,445.92
Price range
$991.13
-
$2,002.28
Increased shares by 50.8% (+2.65 Thousand shares)
Q3 2021
Avg closing price
$2,066.31
Price range
$1,665.00
-
$2,981.25
New holding (+5.22 Thousand shares)
Q2 2021
Avg closing price
$4,935.00
Price range
$2,711.25
-
$7,998.75
Sold -5.06 Thousand shares
Q4 2020
Avg closing price
$5,165.51
Price range
$67.95
-
$12,420.00
Sold 38.6% shares (-3.19 Thousand shares)
Q3 2020
Avg closing price
$12,153.34
Price range
$10,541.25
-
$13,567.50
Increased shares by 85.4% (+3.8 Thousand shares)
Q2 2020
Avg closing price
$11,282.95
Price range
$9,326.25
-
$12,903.75
Increased shares by 432.2% (+3.61 Thousand shares)
Q1 2020